| Literature DB >> 27796743 |
Saghar Ghasemi Firouzabadi1, Roxana Kariminejad2, Roshanak Vameghi3, Hossein Darvish4, Hamid Ghaedi4, Susan Banihashemi1, Mahboubeh Firouzkouhi Moghaddam5,6, Peyman Jamali7, Hassan Farbod Mofidi Tehrani8, Hossein Dehghani1, Mehrnaz Narooie-Nejad9, Javad Jamshidi10, Abbas Tafakhori11, Saeid Sadabadi12, Hossein Najmabadi1,2, Farkhondeh Behjati13.
Abstract
Autism is a common neurodevelopmental disorder estimated to affect 1 in 68 children. Many studies have shown the role of copy number variants (CNVs) as a major contributor in the etiology of autism with the overall detection rate of about 10-15 % and over 20 % when syndromic forms of autism exist. In this study, we used array CGH to identify CNVs in 15 Iranian patients with autism. To elevate our diagnostic yield, we selected the sporadic patients who had additional clinical features including intellectual disability (ID), craniofacial anomaly, and seizure. Six out of 15 patients showed clinically relevant CNVs including pathogenic and likely pathogenic copy number gains or losses. We report a novel gene duplication syndrome (10q21.2q21.3 microduplication) and present a new evidence for VIPR2 duplication, as a candidate gene for autism. Furthermore, we describe the first manifesting carrier female with deletion of SLC6A8 and BCAP31 genes on Xq28. Our findings suggest that there might be a higher prevalence of clinically significant CNVs in patients with autism and additional clinical manifestations. The CNV analysis in such patients could lead to the discovery of novel syndromes as well as unraveling the etiology of autism.Entities:
Keywords: 10q21.2q21.3 microduplication; ASMTL; Array CGH; Autism; BCAP31; CHRNA7; CNV; GPRIN2; Iran; SLC6A8; VIPR2
Mesh:
Substances:
Year: 2016 PMID: 27796743 DOI: 10.1007/s12035-016-0202-y
Source DB: PubMed Journal: Mol Neurobiol ISSN: 0893-7648 Impact factor: 5.590